Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
14.81
+0.57 (4.00%)
At close: Jun 12, 2026, 4:00 PM EDT
14.70
-0.11 (-0.74%)
After-hours: Jun 12, 2026, 6:34 PM EDT
Relay Therapeutics Market Cap
Relay Therapeutics has a market cap or net worth of $3.23 billion as of June 12, 2026. Its market cap has increased by 511.25% in one year.
Market Cap
3.23B
Enterprise Value
2.62B
1-Year Change
511.25%
Ranking
Category
Stock Price
$14.81
Market Cap Chart
Since July 16, 2020, Relay Therapeutics's market cap has increased from $3.03B to $3.23B, an increase of 6.36%. That is a compound annual growth rate of 1.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 3.23B | 120.12% |
| Dec 31, 2025 | 1.47B | 112.63% |
| Dec 31, 2024 | 689.62M | -49.19% |
| Dec 29, 2023 | 1.36B | -24.86% |
| Dec 30, 2022 | 1.81B | -45.57% |
| Dec 31, 2021 | 3.32B | -11.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Crinetics Pharmaceuticals | 3.54B |
| NewAmsterdam Pharma Company | 3.54B |
| Denali Therapeutics | 3.34B |
| Viking Therapeutics | 3.32B |
| Telix Pharmaceuticals | 3.20B |
| Structure Therapeutics | 3.08B |
| Arcutis Biotherapeutics | 3.08B |
| Dyne Therapeutics | 2.97B |